Ophthalmological morbidity in very-low-birthweight infants with bronchopulmonary dysplasia

O A Ajayi1, D Raval, N Lucheese

  • 1Division of Neonatology, Cook County Hospital, Chicago, Illinois, USA.

Insights

Infants born weighing less than 1250g with bronchopulmonary dysplasia face higher risks of retinopathy of prematurity and related ocular sequelae. Early intervention is crucial for these high-risk premature infants.

Area of Science:

  • Neonatal ophthalmology
  • Perinatal medicine
  • Pediatric pulmonology

Background:

  • Retinopathy of prematurity (ROP) and bronchopulmonary dysplasia (BPD) are significant morbidities in premature infants.
  • Ocular sequelae can result from ROP, impacting long-term visual function.
  • Understanding the interplay between ROP, ocular sequelae, and BPD is crucial for early intervention.

Purpose of the Study:

  • To investigate the relationship between retinopathy of prematurity (ROP), its ocular sequelae, and bronchopulmonary dysplasia (BPD) in very low birth weight infants.
  • To identify risk factors for ROP in this vulnerable population.
  • To assess the impact of BPD on the development of ROP and subsequent ocular complications.

Main Methods:

  • Prospective analysis of ophthalmological data from 67 infants weighing < 1250g at birth.
  • Infants underwent at least two eye examinations before discharge and follow-up at 12-18 months postconceptual age.
  • Comparison of outcomes between infants with severe BPD and controls, with adjustment for BPD in sequelae analysis.

Main Results:

  • Incidence of any ROP was 33%, severe ROP was 25%.
  • Infants with severe BPD had 1.7x higher odds of any ROP and 1.8x higher odds of severe ROP.
  • Incidence of ocular sequelae was 45%; ROP increased odds of sequelae (OR 2.3-2.64), with adjusted ORs of 1.27-1.36 when accounting for BPD.

Conclusions:

  • Bronchopulmonary dysplasia is an independent risk factor for ophthalmologic morbidity in premature infants.
  • Lower birth weight, gestational age, acidosis, and hypoxemia are predictors of ROP.
  • Future studies on therapies for chronic lung disease should adjust for the presence of underlying lung disease when evaluating effects on ROP.

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...